Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

  1. Castañón, E.
  2. Rolfo, C.
  3. Viñal, D.
  4. López, I.
  5. Fusco, J.P.
  6. Santisteban, M.
  7. Martin, P.
  8. Zubiri, L.
  9. Echeveste, J.I.
  10. Gil-Bazo, I.
Zeitschrift:
Journal of Translational Medicine

ISSN: 1479-5876

Datum der Publikation: 2015

Ausgabe: 13

Nummer: 1

Art: Artikel

DOI: 10.1186/S12967-015-0622-X GOOGLE SCHOLAR lock_openOpen Access editor